Statistical analysis All data were expressed as mean SD and analyzed by a one-way analysis of variance, followed by the post hoc least significant difference test to determine the level of significance
A total of 50 participants (men and women, 3560 years of age) with dry skin, skin moisture content of 49% or less, or crows feet greater than grade 3 were tested for 12 weeks in this double-blind, randomized, parallel, placebo-controlled study (equal numbers of subjects were in the APCP or placebo groups)
Millions taking GLP-1 medications wonder if they can eventually stop treatment without gaining weight back
Medications like Ozempic, Wegovy, and other injectables have gained popularity as treatments for diabetes, obesity, and other weight-related ailments or conditions
Compliance Category Laboratory Developed Test (LDT) Note Additional information related to the test
Below is a current snapshot of where retatrutide stands what the drug is, what the Phase 3 data look like, when approval is realistically expected, and what your safe options are right now
